| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 57, Issue 2 138-147, Copyright © 1995 by American Psychosomatic Society
ORIGINAL ARTICLES |
RM Kaplan, JP Anderson, TL Patterson, JA McCutchan, JD Weinrich, RK Heaton, JH Atkinson, L Thal, J Chandler and I Grant
Naval Hospital, San Diego, La Jolla, California, USA.
To evaluate the validity of the Quality of Well-Being Scale (QWB) for studies of patients with human immunodeficiency virus (HIV) disease, 514 men were studied who were divided among four categories: Centers for Disease Control and Prevention (CDC) Group A (N = 272), CDC-B (N = 81), CDC-C (N = 47), and uninfected male controls (N = 114). The QWB and a variety of medical, neuropsychological, and biochemical measures were administered to all participants. When QWB scores were broken down by HIV group, the CDC-C group was significantly lower (.614) than the CDC-B (.679), CDC-A (.754), or control group (.801). The difference between Groups CDC-C and CDC-A was about .14 units of well-being, which suggests that individuals lose 1/7 equivalents of 1 well year of life for each year they are in Group CDC-C in comparison to the asymptomatic group (Group CDC-A). In comparison to the controls, this would equal a 1-year of life loss for each seven infected individuals. The QWB was shown to be significantly associated with CD4+ lymphocytes (p < .001), clinician ratings of neuropsychological impairment (p < .04), neurologists ratings of dysfunction (p < .001), and all subscales of the Profile of Mood States. Baseline QWB scores were significant prospective predictors of death over a median follow-up time of 30 months. Multivariate models demonstrated high covariation between predictors of QWB. It was concluded that the QWB is a significant correlate of biological, neuropsychological, neurological, psychiatric, and mortality outcomes for male HIV-infected patients.
This article has been cited by other articles:
![]() |
S. D. Ramsey, S. D. Sullivan, and R. M. Kaplan Cost-Effectiveness of Lung Volume Reduction Surgery Proceedings of the ATS, May 1, 2008; 5(4): 406 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kaplan and A. L. Ries Health-related Quality of Life in Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 561 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Ramsey and S. D. Sullivan Evidence, Economics, And Emphysema: Medicare's Long Journey With Lung Volume Reduction Surgery Health Aff., January 1, 2005; 24(1): 55 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kaplan, A. L. Ries, J. Reilly, and Z. Mohsenifar Measurement of Health-Related Quality of Life in the National Emphysema Treatment Trial Chest, September 1, 2004; 126(3): 781 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.W. Jones and R.M. Kaplan Methodological issues in evaluating measures of health as outcomes for COPD Eur. Respir. J., June 1, 2003; 21(41_suppl): 13S - 18s. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Cronan, E. R. Serber, H. R. Walen, and M. Jaffe The Influence of Age on Fibromyalgia Symptoms J Aging Health, August 1, 2002; 14(3): 370 - 384. [Abstract] [PDF] |
||||
![]() |
D. C. ANGUS, A. A. MUSTHAFA, G. CLERMONT, M. F. GRIFFIN, W. T. LINDE-ZWIRBLE, T. T. DREMSIZOV, and M. R. PINSKY Quality-adjusted Survival in the First Year after the Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1389 - 1394. [Abstract] [Full Text] |
||||
![]() |
R. A. Williams, B. L. Brody, R. G. Thomas, R. M. Kaplan, and S. I. Brown The Psychosocial Impact of Macular Degeneration Arch Ophthalmol, April 1, 1998; 116(4): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Muldoon, S. D Barger, J. D Flory, and S. B Manuck What are quality of life measurements measuring? BMJ, February 14, 1998; 316(7130): 542 - 545. [Abstract] [Full Text] |
||||
![]() |
D. N. Kerner, T. L. Patterson, I. Grant, and R. M. Kaplan Validity of the Quality of Well-Being Scale for Patients with Alzheimer's Disease J Aging Health, February 1, 1998; 10(1): 44 - 61. [Abstract] [PDF] |
||||
![]() |
T. E. Hughes, R. M. Kaplan, S. J. Coons, J. R. Draugalis, J. A. Johnson, and T. L. Patterson Construct Validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected Patients Med Decis Making, October 1, 1997; 17(4): 439 - 446. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |